Exosome-derived circKIF20B suppresses gefitinib resistance and cell proliferation in non-small cell lung cancer

Si-Liang Wei,Jing-Jing Ye,Li Sun,Lei Hu,Yuan-Yuan Wei,Da-Wei Zhang,Meng-Meng Xu,Guang-He Fei
DOI: https://doi.org/10.1186/s12935-023-02974-y
IF: 6.429
2023-07-03
Cancer Cell International
Abstract:The gefitinib resistance mechanism in non-small cell lung cancer (NSCLC) remains unclear, albeit exosomal circular RNA (circRNA) is known to possibly play a vital role in it.
oncology
What problem does this paper attempt to address?